最高の悪性黒色腫医師 - トップ100名の医師

900件以上の黒色腫処置を実施 – ビュレント・カラゴズ医師は、アナドル医療センターにて免疫療法および分子標的療法を専門としています。

• 33年の経験 の腫瘍内科診療経験
• イスタンブール・オカン大学医学部 教授
• トルコ腫瘍内科学会 会員
• がん研究分野における学術論文40件以上を発表

Eda Tanrikulu教授は転移性悪性黒色腫を専門とし、アナドル医療センターにおけるがん症例評価においてリーダーシップを発揮しています。

• 腫瘍内科の専門医資格を有し、21年の経験以上の臨床経験を持つ
• トルコ腫瘍内科専門医試験において全国3位を獲得
• 腫瘍学における国際臨床研究を主導
• ハイダルパシャ・ヌムネ病院にて主任研究員を歴任

Mustafa Solak氏は、ヒサール・インターコンチネンタル病院にて、黒色腫を含む1,100件以上のがん治療を実施しています。

• 腫瘍学における20年の経験の経験
• ハジェテペ大学がん研究所にて研修
• テキサス大学MDアンダーソンがんセンターに勤務
• 黒色腫を含むさまざまながんを専門とする

Dr. Banu Atalar is a board-certified radiation oncologist (Türkiye, 2004). She is a Full Professor at Acibadem MAA University (2018–present) and a clinician at Anadolu Medical Center (2026–present). She trained at Istanbul and Cerrahpaşa. In 2011, she completed a Stanford clinical research fellowship in stereotactic radiosurgery. Her practice focuses on CNS, thoracic, and GI tumors. About 75% of her care involves SRS and MR‑guided adaptive SRS.

Her honors include the ASCO IDEA award (2004), the IASLC International Mentorship Award (2018), and H.FACR (2025). She has 72 international peer‑reviewed publications. Her leadership roles include President of the Turkish Society for Radiation Oncology (2025–27) and Chair of the ESTRO National Societies Committee (2024–27). She served on the ASCO Resource‑Stratified Guidelines Committee (2013–18) and on RSS meeting and nomination committees. She organized national congresses (2023, 2025) and has been an invited speaker at major meetings.

Prof. Hüseyin Baloğlu is a pathology specialist at Anadolu Medical Center in Gebze, Kocaeli, Turkey. He focuses on molecular pathology, surgical pathology, and tumour biopsy and diagnostics.

Education and accreditations: MD, GATA Medical School (1986). Pathology specialty training, GATA (1992). Associate Professor (Doçent), GATA (2004). Visiting scholar at Albert Einstein College of Medicine (New York) and Heidelberg University.

Achievements: author of over 600 peer‑reviewed publications. Holds a patent in molecular diagnostics for thyroid cancer. Leads liquid biopsy and precision oncology services.

ガレニア病院にて、メラノーマ治療を専門とする外科腫瘍学の認定専門医。

• メラノーマに重点を置いた外科腫瘍学を専門とする
• 2030年までConacem認定取得
• メキシコ腫瘍学会（SMEO）会員
• 2020年よりアナワク大学にて大学教員として従事

メリムスキー教授は、スーラスキー医療センターの軟部組織・骨腫瘍科を率い、肉腫およびメラノーマの専門診療において41年の経験以上の経験を有しています。

• ワイツマン科学研究所・腫瘍免疫学研究室 上級研究員
• ESMO 肉腫・骨腫瘍部門 ファカルティメンバー
• ヨーロッパ最高峰の肉腫センターであるギュスターヴ・ルッシー研究所にて研鑽
• 抗メラノーマ抗体に関する修士論文を発表

Head of Teaching at the Puerto Vallarta Regional Hospital

2020-2023

Medical records manager at the Regional Hospital of Puerto Vallarta 2 months 2020

General practitioner in private medical office

2015-2022

Doctor in charge of weight control clinic

2013-2014

Medical assistant in dermatology clinic

2008-2013

Medical Assistant in Dermatological procedures.

 Medical Assistant in minimally invasive surgical procedures

 Operation of fractional laser machine - IPIXEL-ER and

facial rejuvenation with IPL.

 Experience in laser hair removal with Intense Pulsed Light and

radiofrequency

 Experience with ultrasonic cavitation

 Experience with ultraviolet (UV) light phototherapy machine for the

treatment of psoriasis and vitiligo.

 Experience assisting in Botox and Fillers procedures.

 Biomagnet certified by the Higher Institute of Biomagnetism

doctor ISAAC GOIZ DURAN

 Experience in clinical records

 Training in continuing education and professional development of teachers

Professor Dov Zippel is a general surgeon and surgical oncologist. He specializes in breast disease and melanoma. He leads the Meirav Breast Center at Sheba Medical Center. He also serves at the Ella Lemelbaum Institute for Immuno-Oncology. In 2025, Forbes Israel named him to its Best Doctors list.

Expertise: advanced care for benign and malignant breast tumors. Minimally invasive and breast-conserving surgery. Surgical treatment of melanoma and other skin cancers.

Accreditations: MD, Tel Aviv University. Residency in general surgery, Sheba Medical Center. Fellowship in surgical oncology, University of Calgary. Board-certified in general surgery and surgical oncology. Research includes intact breast lesion excision and perioperative BRAF inhibitors for stage III melanoma.

Dr. David Kuczer is a specialist in radio-oncology with many years of experience in cancer diagnosis and treatment. He offers fast access to precise radiotherapy based on current scientific standards.

He is a member of the Cancer Center at the Vienna Private Clinic. He presents each patient to the in-house tumor board. This allows an interdisciplinary discussion by an internationally renowned team and helps select the best treatment.

All radiation treatments are provided in close cooperation with Amethyst Radiotherapy at the Vienna Private Clinic.

Personal information

Title: Professor Doctor

Branch: Radiation Oncology

Work History:

1 GATA Military Medical Faculty

2 Gayrettepe Florence Nightingale Hospital

3 T.R. Demiroğlu Bilim University \ Associate Professor

4 T.R Demiroğlu Bilim University \ Professor

Medical Specialties and Subspecialties:

1 Head and Neck Cancers

2 Radiation Oncology

Priority treatments:

1 Prostate cancer

2 Conformal treatments

Special advanced health technologies:

1 Truebeam Stx Technology

2 Halcyons

Education

1991 - Istanbul University Istanbul Faculty of Medicine

1996 - Istanbul University Cerrahpaşa Faculty of Medicine Radiation

Oncology Specialization Training

Activities • Prevention, research and early diagnosis of cancer • Palliative care in cancer • Cytotoxic chemotherapy • Hormontherapy • Targeted treatment • Immunotherapy Education • 2004 -2010 - Istanbul University, Istanbul faculty of medicine • 2011-2015 - Istanbul University, Istanbul faculty of medicine, internal medicine specialist • 2013-2014 - Cleveland Clinic Endocrinology Department, research associate • 2016-2019 Bezmiâlem Foundation University Medical Oncology Subdivision • Dissertation: Prognostic value of absolute monocyte count in patients with mantle cell lymphoma. • Subdivision Dissertation: An effect of adjuvant chemotherapy on lipid profile and anthropometric parameters in patients with breast and colon cancer. Publications • Circulating Thyroid-Stimulating Hormone Receptor Messenger RNA as a Marker of Tumor Aggressiveness in Patients with Papillary Thyroid Microcarcinoma. Aliyev A, Gupta M, et al. Endocr  18. • The utility of peripheral thyrotropin receptor mRNA in the management of differentiated thyroid cancer. • Aliyev A, Soundararajan S, Bucak E et al. Surgery.  • Diagnostic accuracy of circulating thyrotropin receptor messenger RNA combined with neck ultrasonography in patients with Bethesda III-V thyroid cytology. Aliyev A, Patel J, Brainard J, et al. Surgery.2016 Jan;159(1):113-7. doi: 10.1016/j.surg.2015.06.063. Epub 2015 Oct 9. • Role of Urotensin-2 in 5-Fluorouracil-Related Arterial Vasoconstriction in Cancer Patients. Seker M, Aliyev A, et al. Oncol Res Treat. Epub 2018 Aug 20. • Pertuzumab, trastuzumab and taxane-based treatment for visceral organ metastatic, trastuzumab-naive breast cancer: real-life practice outcomes. Esin E, Oksuzoglu B, Bilici A, Aliyev A. Cancer Chemother Pharmacol.2019 Jan; Epub 2018 Oct 30. • Usefulness of serum M30 and M65 levels to predict response to neoadjuvant chemotherapy in patients with breast cancer. Turk HM, Aliyev A, Celik RS. Curr Probl Cancer.2019 Jul 29. pii: currproblcancer.2019.06.009. • Prognostic impact of primary tumor location on survival in metastatic colorectal cancer patients: A single center experience. Tarik Demir, Murat Araz, Altay Aliyev. Medicine Science International Medicine Journal. • Oral presentations 

• Education: 
•  
• 2001-2007: University of Ioannina Medical School, Greece.
• 2007: Degree in Medicine.
• 2013: Doctoral degree from the Medical School of the Johann Wolfgang Goethe University, Frankfurt (Dr. Med)
• 09.2016 – Today: Master’s in Healthcare Business Studies.

Professional experience:

04.2009 – 04.2013: Resident in the Department for Radiation Oncology, Klinikum Offenbach

05.2013 – 12. 2015: Senior physician in the Department for Radiation Oncology, Klinikum Offenbach

• 01.2016 – 06.2017: Senior physician in the Department of interventional Radiation Oncology, Medical Center Athens
•  
• 07.2017 – Today: Head of the Department of Radiation Oncology at the German Oncology Center, Limassol, Cyprus.

Dr. Yuri Goldes is a general surgeon with more than 20 years of clinical experience. He specializes in upper gastrointestinal and oncologic surgery. He is Deputy Director of the Department of General Surgery and Transplantation at Sheba Medical Center in Tel Aviv. He also leads the Upper GI Surgery Unit. He was named to Forbes Israel’s Best Doctors in 2025. He is ranked among Israel’s Best Gastrointestinal Surgeons by Forbes. In 2019, he received the Israeli Ministry of Health “Best Doctor of the Year” award.

He is an expert in advanced minimally invasive and robotic surgery. He treats diaphragmatic hernia, achalasia, GERD, and gallbladder disease. He also performs oncologic surgery for pancreatic, gastric, and esophageal cancers. He uses laparoscopic and robotic techniques.

He pioneered some of Israel’s first robotic oncologic resections of the stomach and pancreas. He is among a small group worldwide who perform minimally invasive Whipple procedures (pancreaticoduodenectomy) using advanced laparoscopy. He applies methods that improve outcomes and speed recovery. He provides personalized care.

Dr. Osama Abdel Mohimen Mohamed is Head of the Hematology Unit at Shefaa Al Orman Oncology Hospitals. He is also a consultant in medical oncology and hematology at Shefa El Orman Hospital (NGO), Luxor (2019–present).

He diagnoses and treats acute and chronic leukemia, lymphoma, myeloma, myelodysplastic syndromes, and myeloproliferative neoplasms. He also manages complications of solid tumors.

Background: He served at the National Cancer Institute, Cairo University, as a medical oncology resident, then demonstrator and assistant lecturer (2008–2022). Earlier, he was a house officer (2006–2007). He also held specialist roles at Al Salam International, Al Molalmen, and BAHEYA Oncology Center (NGO).

Memberships: ESMO (2008–present). American Society of Bone Marrow Transplantation (2009). ASH (2010).

Experience

2022 PRIVATE MEDIPOL BAHÇELİEVLER HOSPITAL

2021 - 2021 Prof. Dr. Cemil Taşçıoğlu City Hospital, Medical Oncology Clinic Education Officer

2021 - 2021 Prof. Dr. Cemil Taşçıoğlu City Hospital

2020 - 2021 Yüzüncü Yıl University Faculty of Medicine

2020 - 2021 Head of the Department of Medical Oncology, Yüzüncü Yıl University Faculty of Medicine, Assoc. Dr.  

2018 - 2021 Lecturer - Yüzüncü Yıl University Faculty of Medicine, Head of Medical Oncology Department  

2018 - 2021 Yüzüncü Yıl University Faculty of Medicine

2015 - 2018 University of Health Sciences, Okmeydanı Training and Research Hospital

2015 - 2018 University of Health Sciences, Okmeydanı Training and Research Hospital, Medical Oncology Clinic, Sub-branch assistant

2012 - 2015 Kanuni Sultan Süleyman Training and Research Hospital, Internal Medicine specialist

2012 - 2015 Suleiman the Magnificent Training and Research Hospital,

2008 - 2012 Haseki Training and Research Hospital

2006 - 2008 Kızıltepe No. 3 Health Center General Practitioner.

Education

2018

İstanbul Okmeydanı Eğitim ve Araştırma Hastanesi, Tıbbı Onkoloji

2018

İstanbul Okmeydanı Eğitim ve Araştırma Hastanesi, Tıbbı Onkoloji, İstanbul Okmeydanı Eğitim ve Araştırma Hastanesi, Tıbbı Onkoloji

2012

İstanbul Haseki Eğitim ve Araştırma Hastanesi, İç Hastalıkları, İstanbul Haseki Eğitim ve Araştırma Hastanesi, İç Hastalıkları

2012

İstanbul Haseki Eğitim ve Araştırma Hastanesi, İç Hastalıkları

2007

Uludağ Üniversitesi Tıip Fakültesi, Tıip Fakültesi, Uludağ Üniversitesi Tıip Fakültesi, Tıip Fakültesi

シナン・カラアスラン博士は、乳がん、大腸がん、泌尿生殖器系がんの管理において最高の腫瘍医の一人です。

職務経験

• 2014年から — アナドル医療センターの腫瘍内科医
• 2012-2014 — メディカルパークホスピタルの腫瘍内科医
• 2011-2012 — コジャエリ・デリンセ教育研究病院の腫瘍内科医
• 2010-2011 — エルズルム地域教育研究病院の腫瘍内科医
• 2009-2010 — トルコ武装軍、ギュルハネ軍事医科大学での軍務中の腫瘍内科学の専門家
• 2006-2009 — チェラッパシャ医科大学腫瘍内科学科での腫瘍内科学フェロー
• 2003-2006 — バイランパシャ国立病院の内科専門医
• 1997-2003 — ハセキ教育研究病院の内科研修生兼内科専門医。

教育

• 1997 — イスタンブール大学イスタンブール医科大学 — 一般医学の学位
• 2002 — ハセキ研修病院 — 内科の専門
• 2009 — イスタンブール大学、チェラッパシャ医科大学 — 腫瘍内科の専門。

所属

• トルコ医学会
• トルコ腫瘍医学会
• トルコ肺がん学会。

900件以上の治療実績 – セルカン・ケシキン医師は、進行期黒色腫治療を専門とする高評価の腫瘍内科医です。

• トルコ腫瘍内科専門医資格試験で第1位を獲得
• 国際腫瘍学専門誌に42本の論文を発表
• 世界有数の腫瘍学学会であるASCOおよびESMOの会員
• 25年の経験 の複雑ながん症例の診療経験
• 化学療法、免疫療法、および分子標的療法の専門家

イェシム・ユルドゥルム教授は、がん免疫療法および分子標的治療を専門とし、80を超える国際学術論文および共著書籍を有しています。

• 欧州臨床腫瘍学会（ESMO）会員
• マウント・バーノン・キャンサーセンターにてメラノーマおよび腎臓がんクリニックの研修を修了
• イスタンブール・ハリチ大学教授
• アナドル医療センターにて22年の経験の診療経験

学歴と職歴

バルセロナ大学（バラゲール、1958年）医学・外科の博士

医療-外科皮膚科の専門家であり、45年以上の経験を持つ 

サンパウ大学病院の皮膚科の臨床責任者であり、バルセロナ自治大学のモーズユニットのディレクター t

テクノン医療センターの創設以来の教員の一員

🧠 専門分野と業績

皮膚がんの予防、診断＆治療 — オンコダーマトロジーのパイオニア 

モーズ顕微鏡手術 — 1,400〜2,000件以上の施術で、従来の切除よりも高い治癒率 

光動力学療法、皮膚がんスクリーニング、太陽保護、STIの管理

🌍 学術的役割とリーダーシップ

サンパウ大学病院の皮膚科サービスの責任者

UABでのモーズ手術トレーニングプログラムのディレクター

Institut de Dermatologia GarcésとDerma Associatsの創設者＆ディレクター

📚 出版物と教育

以下を含む複数の科学論文の著者:

広範囲の眉の欠損の修復 (2021)

上唇紅の欠損の再建 (2016) t

人気のある書籍 「Cuando calienta el sol」（「When the Sun Shines」）、健康な日焼けのルーチンに関するガイドの著者

🌐 会員資格と認知

国際皮膚外科協会（ISDS）、ヨーロッパモーズ顕微鏡手術協会（ESMS）、スペイン皮膚科学および性病学アカデミー（AEDV）の会員 

認知されたトップ皮膚科医、TopDoctorsでの平均評価は4.9/5、AiroMedicalでは9.9/10 u

💬 会話できる言語

スペイン語、カタロニア語、英語に流暢

📍 診療所所在地＆連絡先

テクノン医療センター
Carrer de Vilana, 12, 08022 バルセロナ
 

相談時間：
月曜日～金曜日 9:00–15:00 & 15:00–20:00 

⭐ ガルセス博士で予約する理由？

🥇 世界クラスのモーズ手術のパイオニアであり、最高水準の治癒率

🎯 精密に基づいた個別化された治療と美容再建治療

👨‍⚕️ 広範な学術的および教育的なプロファイルで、最先端のケアを保証

🌐 優れた国際的な評判、多言語対応、患者に焦点を当てた姿勢

予約の準備はできましたか？
オンラインおよび対面での相談を提供し、Bookimedでスムーズな予約プロセスを提供します。彼のクリニックは、多言語での専用の患者ケアと進んだ皮膚がん治療を提供しています。